Lachisanu, bungwe loyang'anira mankhwala ku European Union lidapereka 'malangizo' othandizira kugwiritsa ntchito mwadzidzidzi mankhwala atsopano othana ndi coronavirus opangidwa ndi kampani yaku America yakumayiko osiyanasiyana. Merck mothandizana ndi Ridgeback Biotherapeutics, ngakhale silinavomerezedwe ndi akuluakulu aku US.
The European Medicines Agency (EMA) walimbikitsa kugwiritsa ntchito mwadzidzidzi kwa MerckPiritsi lothandizira odwala omwe ali pachiwopsezo cha COVID-19 pomwe milandu yatsopano ya coronavirus ikukwera kudera lonse la Europe.
M'mawu akuti, EMA adati mankhwala otchedwa Lagevrio - omwe amadziwikanso kuti molnupiravir kapena MK 4482 - "atha kugwiritsidwa ntchito pochiza akuluakulu omwe ali ndi COVID-19 omwe safuna mpweya wowonjezera komanso omwe ali pachiwopsezo chachikulu chokhala ndi COVID-19."
Woyang'anira EU adati chithandizochi chiyenera kuperekedwa posachedwa COVID-19 atapezeka komanso mkati mwa masiku asanu chiyambireni zizindikiro. Mankhwalawa ayenera kumwedwa kawiri pa tsiku kwa masiku asanu.
The EMA anatchula zotsatira za mapiritsi, kuphatikizapo kutsegula m'mimba pang'ono kapena pang'ono, nseru, chizungulire ndi mutu. Mankhwala osavomerezeka kwa amayi apakati.
Woyang'anira adalengeza kale Lachisanu kuti wayamba kuwunikanso mankhwala a Pfizer Paxlovid a COVID-19 ndi cholinga chomwechi "kuthandizira akuluakulu adziko" omwe angasankhe kugwiritsa ntchito kwawo koyambirira asanavomereze kutsatsa chifukwa cha kukwera kwa milandu ndi kufa ku Europe.
Lero, Austria yalengeza kuti ilowa mdziko lonse lotsekeka kuyambira Lolemba ndikupangitsa kuti katemera akhale wovomerezeka, pomwe akuluakulu azaumoyo ku Germany ati dzikolo lasanduka "chipwirikiti chachikulu."
Onse a Pfizer ndi Merck apempha kuti avomereze mankhwala awo a coronavirus ku US Food and Drug Administration, koma sizikudziwika kuti angapatsidwe liti.
ZOMWE MUNGACHITE PA NKHANIYI:
- The regulator announced earlier on Friday that it had begun reviewing Pfizer's medicine Paxlovid for COVID-19 with the same goal “to support national authorities” who may decide on its early use prior to marketing authorization in light of rising cases and deaths in Europe.
- In a statement, EMA said the drug called Lagevrio – also known as molnupiravir or MK 4482 – “can be used to treat adults with COVID-19 who do not require supplemental oxygen and who are at increased risk of developing severe COVID-19.
- The European Medicines Agency (EMA) has recommended the emergency use of Merck's pill for the treatment for clinically vulnerable COVID-19 patients as new coronavirus cases spike across the European continent.
